Psychiatry and Neurology, Neurology · Boston, MA
NPI
1396957064
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
75 Francis St, Dept. of Neurology
Boston, MA, 02115
Phone (617) 732-7432
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
259 services
Medicare patients, 2024
168
Average age 66
Drug cost, 2024
$2.9M
1,551 prescriptions
Company payments, 2023
$6,852
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher A Severson was code 99214 (office e&m - established), 209 times for 142 patients. In total Christopher A Severson billed 259 services in 7 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 209 | 142 | $70.07 | $15K |
| 99214 Office E&M - Established | Office | 25 | 24 | $96.24 | $2,406 |
By year: 2022 $19K for 250 services; 2023 $18K for 233 services; 2024 $19K for 259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher A Severson prescribed most often to Medicare patients was Baclofen, with 202 prescriptions and refills. In total Christopher A Severson wrote 1,551 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Baclofen Generic | 202 | 449 | 58 | $8,950 |
| Teriflunomide Generic | 151 | 161 | 19 | $409K |
| Dimethyl Fumarate Generic | 133 | 155 | 19 | $131K |
| Gabapentin Generic | 122 | 192 | 30 | $3,305 |
| Dalfampridine Er Dalfampridine | 118 | 160 | 19 | $43K |
| Modafinil Generic | 70 | 100 | 17 | $2,777 |
| Fingolimod Fingolimod Hcl | 61 | 63 | Under 11 | $148K |
| Copaxone Glatiramer Acetate | 59 | 59 | Under 11 | $355K |
| Kesimpta Pen Ofatumumab | 41 | 41 | Under 11 | $374K |
| Aubagio Teriflunomide | 37 | 37 | Under 11 | $339K |
| Tizanidine Hcl Generic | 36 | 61 | Under 11 | $498 |
| Mayzent Siponimod | 36 | 42 | Under 11 | $364K |
| Glatiramer Acetate Generic | 34 | 41 | Under 11 | $83K |
| Methylphenidate Hcl Generic | 30 | 30 | Under 11 | $511 |
| Oxcarbazepine Generic | 28 | 42 | Under 11 | $2,310 |
Brand drugs: 257 claims; generic drugs: 1,294 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Christopher A Severson $6,852 ($6,852 in general payments such as food, travel and fees) from 1 company. The largest payer was Genentech USA, Inc. with $6,852.
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. ROG.SW | 5 | $6,852 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.